News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
GBI Enhances Its Position in Radiopharmaceutical Manufacturing Through the Acquisition of a New Contract for Commercial Manufacturing
Wednesday, January 10, 2024GBI BioManufacturing formerly recognized as Goodwin Biotechnology is excited to announce the completion of its second master supply agreement for the commercialization of a radioimmunoconjugate product
Constant Therapeutics Commences Phase 2 Clinical Trial for TXA127 in Ischemic Stroke Recovery with First Patient Dosed
Wednesday, January 10, 2024Constant Therapeutics LLC a biopharmaceutical firm specializing in treatments affecting the Alternative ReninAngiotensin System has commenced its phase clinical trial for TXA This is the companys
Medison Pharma and Regeneron Pharmaceuticals Have Signed an Agreement for the Commercialization of Libtayo® (Cemiplimab) in Various Countries
Tuesday, January 09, 2024Medison Pharma a global pharmaceutical company dedicated to providing access to innovative therapies internationally recently announced an exclusive multinational agreement with Regeneron Ireland DAC
Debiopharm Extends Collaboration with SunRock Biopharma for Antibody-Drug Conjugates Targeting HER3 in EGFR-Mutated Cancers
Tuesday, January 09, 2024Debiopharm a Swiss biopharmaceutical company specializing in cancer and infectious disease treatments has secured an option for an exclusive licensing agreement with SunRock Biopharma SunRock Biopharma
Aegle Therapeutics Corp. Shares Positive Outcomes for the First Participant in Phase 1/2a Clinical Trial Treated with AGLE-102™, a Novel Extracellular Vesicle Therapy
Tuesday, January 09, 2024Aegle Therapeutics Corp has revealed positive results from the initial week evaluation of the first participant in its Phase a clinical trial for AGLE an innovative extracellular vesicle
Orion and Glykos Announce a Collaborative Research Initiative and Licensing Agreement Aimed at Advancing the Development of Next-generation ADCs
Monday, January 08, 2024Orion Corporation and Glykos Finland Oy have jointly announced a research collaboration and licensing agreement for the development of nextgeneration antibodydrug conjugates
Essential Pharma Obtains European Rights to Colobreathe® (Colistimethate Sodium) Through Acquisition From Teva
Monday, January 08, 2024Essential Pharma an international specialty pharmaceutical group committed to providing sustainable access to lowvolume clinically established pharmaceutical products in key therapeutic areas has successfully concluded the acquisition
Nimbus Therapeutics Unveils Enlargement of Its Immunology Drug Discovery Pipeline
Saturday, January 06, 2024Nimbus Therapeutics LLC a biotechnology company known for its innovative computational drug discovery engine has announced the expansion and advancement of its pipeline by introducing discovery programs targeting innate immunity pathways
Rivus Pharmaceuticals has successfully concluded the enrollment phase for the Phase 2a HuMAIN Trial of HU6
Saturday, January 06, 2024Rivus Pharmaceuticals Inc a clinicalstage biopharmaceutical company dedicated to enhancing cardiometabolic health has successfully concluded the enrollment phase for its Phase a HuMAIN trial of HU HU
Anocca Secures GMP Manufacturing License for Advancing Innovative KRAS TCR-T Cell Therapies in Clinical Development
Friday, January 05, 2024Anocca AB a prominent company specializing in T cell receptorengineered T cell therapies has announced that it has received a certificate of good manufacturing practice compliance
